Pulat Bekmuratovich Usmanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pulat Bekmuratovich Usmanov has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Inoyat Zulfiqorovich Zhumaev
Department of Cell Biophysics, Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan
4 shared publications - Shavkat Yusubovich Rustamov
Department of Cell Biophysics, Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan
4 shared publications - Sherzod Niyatkobilovich Zhurakulov
S. Yu. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan, Tashkent, Uzbekistan
4 shared publications - Boboev Sadriddin Nurillo Ugli
Department of Cell Biophysics, Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan
3 shared publications - Abdisalim Abdikarimovich Zaripov
Department of Physiology and Pathology, Tashkent State Medical University, Tashkent, Uzbekistan
2 shared publications - Adilbay Tlepovich Esimbetov
Department of Animal Husbandry and Biotechnology, Samarkand State University of Veterinary Medicine, Samarkand, Uzbekistan
2 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 2 (19) , 2025-2035
Evaluation of the Role of Plasmalemma Ca²+ Transport Systems in the Vasorelaxant Effect of the CAM-68 Alkaloid under In vitro Conditions
This study aims to evaluate how plasma membrane calcium transport mechanisms—specifically L-type calcium channels, receptor-operated calcium channels, and the sodium-calcium exchanger—contribute to the vasorelaxant activity of the alkaloid CAM-68. The isometric contraction force of the aortic rings was recorded using a Grass-Telefactor FT.03 myograph and analysed with the PowerLab data-acquisition software (ADInstruments). Findings indicate that the alkaloid CAM-68 exerts an effective vasorelaxant effect on vascular smooth muscle, which is primarily achieved by modulating intracellular Ca²⁺ concentration.The CAM-68 alkaloid inhibits voltage-dependent L-type Ca2+ channels and receptor-operated Ca2+ channels in the plasma membrane. It also attenuates the activity of the Na⁺/Ca²⁺ exchange in reverse mode. These effects are associated with the modulation of smooth muscle cell Ca²⁺ homeostasis and the attenuation of Ca²⁺ influx across the membrane.
- 25 June 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 2 (19) , 2025-2035
Open AccessEvaluation of the Role of Plasmalemma Ca²+ Transport Systems in the Vasorelaxant Effect of the CAM-68 Alkaloid under In vitro Conditions
This study aims to evaluate how plasma membrane calcium transport mechanisms—specifically L-type calcium channels, receptor-operated calcium channels, and the sodium-calcium exchanger—contribute to the vasorelaxant activity of the alkaloid CAM-68. The isometric contraction force of the aortic rings was recorded using a Grass-Telefactor FT.03 myograph and analysed with the PowerLab data-acquisition software (ADInstruments). Findings indicate that the alkaloid CAM-68 exerts an effective vasorelaxant effect on vascular smooth muscle, which is primarily achieved by modulating intracellular Ca²⁺ concentration.The CAM-68 alkaloid inhibits voltage-dependent L-type Ca2+ channels and receptor-operated Ca2+ channels in the plasma membrane. It also attenuates the activity of the Na⁺/Ca²⁺ exchange in reverse mode. These effects are associated with the modulation of smooth muscle cell Ca²⁺ homeostasis and the attenuation of Ca²⁺ influx across the membrane.
- Open Access
- 20 March 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 1 (19) , 578-591
Role of F-4 Isoquinoline Alkaloid, Dihydroquercetin Flavonoid and Conjugate DKV-6 in Myocardial RyR2 and SERCA2a under Normal and Hypoxic Conditions
Cardiovascular diseases are among the leading causes of death worldwide, according to the World Health Organization. A key pathogenic factor in ischemia and myocardial infarction is the disruption of Ca²⁺ ion homeostasis and impaired function of the sarcoplasmic reticulum (SR) proteins RyR2 and SERCA2a. Therefore, identifying biologically active substances that modulate Ca²⁺ transport via SERCA2a is of significant scientific and practical importance. In this study, the inotropic effects of the isoquinoline alkaloid F-4, the flavonoid dihydroquercetin (DHQ), and their conjugate DKV-6 were investigated using isolated rat heart papillary muscle preparations. Mechanographic results showed that F-4 (120 μM), DHQ (60 μM), and DKV-6 (50 μM) increased papillary muscle contractility by 32.9±3.1%, 51.4±3.4%, and 110.3±3.2%, respectively, compared to control. The post-rest potentiation (PRP) method was employed to assess changes in SR Ca²⁺ levels. The effects of these biologically active compounds (BACs) on RyR2 were studied using tetracaine and ruthenium red, while the role of SERCA2a was evaluated with cyclopiazonic acid (CPA). The results indicated that the positive inotropic effect is closely associated with SERCA2a function. Furthermore, the DKV-6 conjugate exhibits distinct anti-hypoxic activity, effectively counteracting hypoxia-induced impairments in myocardial contractility. Its antiarrhythmic effect appears to be mediated through SERCA2a activation.
- 20 March 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 1 (19) , 578-591
Open AccessRole of F-4 Isoquinoline Alkaloid, Dihydroquercetin Flavonoid and Conjugate DKV-6 in Myocardial RyR2 and SERCA2a under Normal and Hypoxic Conditions
Cardiovascular diseases are among the leading causes of death worldwide, according to the World Health Organization. A key pathogenic factor in ischemia and myocardial infarction is the disruption of Ca²⁺ ion homeostasis and impaired function of the sarcoplasmic reticulum (SR) proteins RyR2 and SERCA2a. Therefore, identifying biologically active substances that modulate Ca²⁺ transport via SERCA2a is of significant scientific and practical importance. In this study, the inotropic effects of the isoquinoline alkaloid F-4, the flavonoid dihydroquercetin (DHQ), and their conjugate DKV-6 were investigated using isolated rat heart papillary muscle preparations. Mechanographic results showed that F-4 (120 μM), DHQ (60 μM), and DKV-6 (50 μM) increased papillary muscle contractility by 32.9±3.1%, 51.4±3.4%, and 110.3±3.2%, respectively, compared to control. The post-rest potentiation (PRP) method was employed to assess changes in SR Ca²⁺ levels. The effects of these biologically active compounds (BACs) on RyR2 were studied using tetracaine and ruthenium red, while the role of SERCA2a was evaluated with cyclopiazonic acid (CPA). The results indicated that the positive inotropic effect is closely associated with SERCA2a function. Furthermore, the DKV-6 conjugate exhibits distinct anti-hypoxic activity, effectively counteracting hypoxia-induced impairments in myocardial contractility. Its antiarrhythmic effect appears to be mediated through SERCA2a activation.
- Open Access
- 30 September 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (3) , 2463-2473
Antiarrhythmic Effect of 1-(3ˊ-Bromophenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride
During the study, the inotropic and antiarrhythmic properties of the alkaloid 1-(3ˊ-Bromophenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (F-25) were investigated. The alkaloid F-25 was shown to exert a negative inotropic effect on the contractile force of rat cardiac papillary muscle, decreasing myocardial contractility by 87.6±4.2% at a concentration of 100 μM compared to the control. To assess the involvement of voltage-gated Na+ channels in providing the negative inotropic effect of the alkaloid F-25, experiments were conducted using lidocaine, a specific blocker of this channel. When the effect of F-25 alkaloid (100 μM) was tested in the existence of lidocaine (IC50=15.4 μM), the amplitude of papillary muscle contraction force was 32.8±3.9%, respectively. The influence of the alkaloid F-25 on Na⁺/Ca²⁺ exchange was examined using NiCl₂, a non-specific blocker of this exchanger. The negative inotropic effect of the alkaloid F-25 (100 μM) on papillary muscle contraction activity in the presence of a 10 mM concentration of NiCl2 in the incubation medium was 42.3±4.2%. The negative inotropic effect of the alkaloid F-25 is exerted mainly by modulating the function of Na+ channels and, in part, the Na+/Ca2+ exchange. The impact of the alkaloid F-25 was also evaluated using an aconitine-induced arrhythmia model, revealing that the compound exhibits strong antiarrhythmic properties
- 30 September 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (3) , 2463-2473
Open AccessAntiarrhythmic Effect of 1-(3ˊ-Bromophenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride
During the study, the inotropic and antiarrhythmic properties of the alkaloid 1-(3ˊ-Bromophenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (F-25) were investigated. The alkaloid F-25 was shown to exert a negative inotropic effect on the contractile force of rat cardiac papillary muscle, decreasing myocardial contractility by 87.6±4.2% at a concentration of 100 μM compared to the control. To assess the involvement of voltage-gated Na+ channels in providing the negative inotropic effect of the alkaloid F-25, experiments were conducted using lidocaine, a specific blocker of this channel. When the effect of F-25 alkaloid (100 μM) was tested in the existence of lidocaine (IC50=15.4 μM), the amplitude of papillary muscle contraction force was 32.8±3.9%, respectively. The influence of the alkaloid F-25 on Na⁺/Ca²⁺ exchange was examined using NiCl₂, a non-specific blocker of this exchanger. The negative inotropic effect of the alkaloid F-25 (100 μM) on papillary muscle contraction activity in the presence of a 10 mM concentration of NiCl2 in the incubation medium was 42.3±4.2%. The negative inotropic effect of the alkaloid F-25 is exerted mainly by modulating the function of Na+ channels and, in part, the Na+/Ca2+ exchange. The impact of the alkaloid F-25 was also evaluated using an aconitine-induced arrhythmia model, revealing that the compound exhibits strong antiarrhythmic properties
- Open Access
- 30 June 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (2) , 1601-1610
Mechanism of Vasorelaxant Action of Isoquinoline Alkaloid F-19 on Rat Aorta
The development of cardiovascular diseases is primarily associated with impaired activity of ion transport systems that ensure Ca2+ homeostasis in vascular smooth muscle cells. Modulation of the function of Ca2+ ion transport systems in smooth muscle cells with biologically active compounds allows the development of new approaches to the pharmacological regulation of Ca2+-dependent processes in cardiovascular diseases. This article studies the mechanisms of the vasorelaxant effect of the isoquinoline alkaloid 1-(3¢-Bromo-4¢-hydroxyphenyl-5¢-methoxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (F-19) on the force of aortic ring contraction. It was found that the alkaloid F-19 exerts a concentration-dependent (5-100 μM) potent vasorelaxant effect on the force of aortic ring contraction induced by KCl and PE. The involvement of the L-type Ca2+ channel in the vasorelaxant effect of the alkaloid F-19 was investigated under conditions of incubation with its specific blocker verapamil. It was found that the role of the L-type Ca2+ channel in the vasorelaxant effect of this alkaloid is minor. The effect of the alkaloid F-19 on Ca2+ transport systems in the SR was also investigated. In this case, PE and caffeine-induced transient aortic contraction in the absence of Ca2+ significantly reduced. At the same time, a decrease in the vasorelaxant effect on aortic contractility was observed under the conditions of incubation with the SERCA inhibitor CPA, the alkaloid F-19. The vasorelaxant effect of the alkaloid F-19 on rat aortic smooth muscle contractility is mediated by several complex mechanisms. The vasorelaxant effect of this alkaloid is provided by inhibiting the entry of Ca2+ ions into the cytosol through plasma membrane potential-dependent L-type Ca2+ channels and the exit of Ca2+ ions into the cytosol through the SR Ca2+ transport systems, and by activating SERCA.
- 30 June 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (2) , 1601-1610
Open AccessMechanism of Vasorelaxant Action of Isoquinoline Alkaloid F-19 on Rat Aorta
The development of cardiovascular diseases is primarily associated with impaired activity of ion transport systems that ensure Ca2+ homeostasis in vascular smooth muscle cells. Modulation of the function of Ca2+ ion transport systems in smooth muscle cells with biologically active compounds allows the development of new approaches to the pharmacological regulation of Ca2+-dependent processes in cardiovascular diseases. This article studies the mechanisms of the vasorelaxant effect of the isoquinoline alkaloid 1-(3¢-Bromo-4¢-hydroxyphenyl-5¢-methoxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (F-19) on the force of aortic ring contraction. It was found that the alkaloid F-19 exerts a concentration-dependent (5-100 μM) potent vasorelaxant effect on the force of aortic ring contraction induced by KCl and PE. The involvement of the L-type Ca2+ channel in the vasorelaxant effect of the alkaloid F-19 was investigated under conditions of incubation with its specific blocker verapamil. It was found that the role of the L-type Ca2+ channel in the vasorelaxant effect of this alkaloid is minor. The effect of the alkaloid F-19 on Ca2+ transport systems in the SR was also investigated. In this case, PE and caffeine-induced transient aortic contraction in the absence of Ca2+ significantly reduced. At the same time, a decrease in the vasorelaxant effect on aortic contractility was observed under the conditions of incubation with the SERCA inhibitor CPA, the alkaloid F-19. The vasorelaxant effect of the alkaloid F-19 on rat aortic smooth muscle contractility is mediated by several complex mechanisms. The vasorelaxant effect of this alkaloid is provided by inhibiting the entry of Ca2+ ions into the cytosol through plasma membrane potential-dependent L-type Ca2+ channels and the exit of Ca2+ ions into the cytosol through the SR Ca2+ transport systems, and by activating SERCA.